MANGALAM Intraday Analysis...

MANGALAM Share Price

Open 149.20 Change Price %
High 149.20 1 Day -1.45 -0.98
Low 145.25 1 Week -4.20 -2.79
Close 146.25 1 Month -6.40 -4.19
Volume 51605 1 Year -114.20 -43.85
52 Week High 273.45
52 Week Low 122.60
MANGALAM Important Levels
Resistance 2 149.91
Resistance 1 148.40
Pivot 146.90
Support 1 144.10
Support 2 142.59
NSE INDIA Most Active Stocks
SREINFRA 86.00 -3.32%
JPASSOCIAT 13.40 0.37%
SUZLON 18.90 -0.53%
IDEA 90.90 -0.76%
SIGNET 16.45 0.00%
BANKBARODA 169.05 4.22%
UNITECH 5.75 0.88%
SBIN 276.50 2.98%
PNB 141.50 4.16%
ICICIBANK 274.75 2.92%
More..
NSE INDIA Top Gainers Stocks
RASOYPR 0.20 33.33%
ATNINTER 0.25 25.00%
AUSTRAL 0.30 20.00%
FCSSOFT 0.30 20.00%
STARPAPER 171.05 19.99%
CIMMCO 89.15 19.99%
BALKRISHNA 84.20 19.86%
GTNTEX 17.35 19.66%
LGBFORGE 7.35 18.55%
SMPL 2.25 18.42%
More..
NSE INDIA Top Losers Stocks
POLYMED 246.95 -54.63%
VKSPL 0.05 -50.00%
FARMAXIND 0.05 -50.00%
NAKODA 0.35 -12.50%
VIPULLTD 60.10 -12.20%
REFEX 23.20 -9.90%
MVL 0.50 -9.09%
MVL 0.50 -9.09%
NLCINDIA 109.80 -8.84%
ZENITHBIR 0.55 -8.33%
More..

Mangalam Drugs And Organics Limited (NSE: MANGALAM)

MANGALAM Technical Analysis 4
As on 24th Mar 2017 MANGALAM Share Price closed @ 146.25 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 165.66 & Sell for SHORT-TERM with Stoploss of 152.32 we also expect STOCK to react on Following IMPORTANT LEVELS.
MANGALAM Target for March
1st Target up-side 170.21
2nd Target up-side 181.07
3rd Target up-side 191.94
1st Target down-side 139.19
2nd Target down-side 128.33
3rd Target down-side 117.46
MANGALAM Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 40.25 Sideways
MFI (14) MFI is 51.08 Sideways
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is 15.32 Range Bound
PSAR Stoploss For Short Sell 157.41
10 Day Avg Volume Traded -26.74 % Less then 10 Day Average Volume
MANGALAM Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
MANGALAM Address
MANGALAM
N/A
MANGALAM Latest News
Mangalam Drugs And Organics Limited   Moneycontrol.com   - 19th Mar 15
Clarification sought from Mangalam Drugs & Organics Ltd   Hindu Business Line   - 19th Mar 15
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011   Hindu Business Line   - 17th Feb 15
Mangalam Drugs' director Rajendra Prasad Mimani resigns   Moneycontrol.com   - 03rd Feb 15
They lied to me for 15 years of my life, says asbestosis-afflicted labourer   Mid-Day   - 21st Jul 14
Fire stops work at Mangalam Organics plant in Maharastra   Business Standard   - 07th Feb 14
CRISIL ratings for Indian debt instruments-Feb 4   Reuters   - 04th Feb 14
Dujodwala Products changes its name to Mangalam Organics   Moneycontrol.com   - 05th Nov 13
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011   Hindu Business Line   - 09th Apr 12
Indian takeovers abroad   The Economist   - 01st Mar 12
Interactive Technical Analysis Chart Mangalam Drugs And Organics Limited ( MANGALAM NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Mangalam Drugs And Organics Limited
MANGALAM Business Profile
Mangalam Drugs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 5.57 crore.The company has reported a standalone sales of Rs 28.21 crore and a Net Loss of Rs 0.97 crore for the quarter ended Sep 2013.The company management includes Govardhan M Dhoot - Chairman, Subhash C Khattar - Ind. Non-Executive Director, Rajendraprasad Mimani - Ind. Non-Executive Director. It is listed on the BSE with a BSE Code of 532637 and the NSE with an NSE Code of MANGALAM.Its Registered office is at No 292, Princess Street, 2nd Floor, Near Flyover,,Marine Lines Mumbai,Maharashtra - 400002.Their Registrars are Link Intime India Pvt. Ltd.